Reply to: "Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface"

Affiliations

¹ Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland.
² Department of Pharmacology and Pediatrics, Servicio de Farmacologia Clinica, University Hospital Virgen de la Victoria, IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain. Electronic address: lucena@uma.es.
³ Department of Medicine, Servicio de Digestivo, University Hospital Virgen de la Victoria IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain.

Comment

Einar S Björnsson et al. J Hepatol. 2024 Jul.

. 2024 Jul;81(1):e48.

doi: 10.1016/j.jhep.2024.03.037. Epub 2024 Mar 28.

¹ Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland.
² Department of Pharmacology and Pediatrics, Servicio de Farmacologia Clinica, University Hospital Virgen de la Victoria, IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain. Electronic address: lucena@uma.es.
³ Department of Medicine, Servicio de Digestivo, University Hospital Virgen de la Victoria IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain.

No abstract available

Comment on

Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface.
Alkashash A, Zhang X, Vuppalanchi R, Lammert C, Saxena R. Alkashash A, et al. J Hepatol. 2024 Jul;81(1):e45-e47. doi: 10.1016/j.jhep.2024.01.023. Epub 2024 Feb 1. J Hepatol. 2024. PMID: 38309439 No abstract available.